Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-001220
Filing Date
2022-01-06
Accepted
2022-01-06 17:03:43
Documents
1
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7917
  Complete submission text file 0000899243-22-001220.txt   9128
Mailing Address
Business Address
MILNE GEORGE M JR (Reporting) CIK: 0001179552 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41199 | Film No.: 22515513

Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Issuer) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations